US FDA Grants Breakthrough Device Designation to Bioretec's Fracture Fixation Device

12:31 AM EST, 12/15/2025 (MT Newswires) -- Finnish medical device company Bioretec (BRETEC.HE) received the US Food and Drug Administration's breakthrough device designation for its biodegradable RemeOs DrillPin. The magnesium alloy technology‑based device is used for the fixation of bone fragments in pediatric and adult patients, and to treat epi-metaphyseal fractures in pediatric patients aged two and above.